Original contributionA comparative trial of three agents in the treatment of acute migraine headache
References (14)
- et al.
Comparative efficacy of chloropromazine and meperidine with dimenhydrinate in migraine headache
Ann Emerg Med
(1989) Parenteral chloropromazine treatment of migraine
Ann Emerg Med
(1983)- et al.
Status migrainosus: Causative and therapeutic aspects
Headache
(1983) Emergency treatment of intractable migraine
Headache
(1986)- et al.
A controlled study of dihydroergotamine in the treatment of acute migraine headache
Headache
(1986) - et al.
Intravenous chloropromazine: Preliminary results in acute migraine
Headache
(1985)
There are more references available in the full text version of this article.
Cited by (119)
The 5-HT<inf>1B</inf> and 5-HT<inf>1D</inf> agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans
2024, Handbook of Clinical NeurologyStatus migrainosus
2024, Handbook of Clinical NeurologyLidocaine versus dexketoprofen in treatment of tension-type headache: A double-blind randomized controlled trial
2021, American Journal of Emergency MedicineSafety and Efficacy of Intravenous Lidocaine for Pain Management in the Emergency Department: A Systematic Review
2018, Annals of Emergency MedicineBenign Headache Management in the Emergency Department
2018, Journal of Emergency MedicineCitation Excerpt :This medication is more efficacious than placebo and comparable to metoclopramide in pain relief. It may be equivalent to ketorolac, and it can reduce the risk of headache relapse at 24 hours (9–11,17,19,20). However, this medication is not commonly used in the United States.
Neuroemergency Clinical Trials: Migraine
2018, Handbook of Neuroemergency Clinical Trials: Second Edition
Presented at the Canadian Royal College of Physicians Annual Meeting in Ottawa, Canada, September 1988.
Copyright © 1990 Published by Mosby, Inc.